OncoMatch/Clinical Trials/NCT07186192

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

Is NCT07186192 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for hematologic malignancies.

Phase 3RecruitingCity of Hope Medical CenterNCT07186192Data as of May 2026

The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).

Check if I qualify

Extracted eligibility criteria

Cancer type

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Non-Hodgkin Lymphoma

Multiple Myeloma

Myelodysplastic Syndrome

Chronic Lymphocytic Leukemia

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

City of Hope Medical Center · Duarte, California

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify